Avego is a multi-strategy investment firm specializing in healthcare. Our mission is to unite our industry expertise and capital with entrepreneurs and management teams to deliver successful results and improve the lives of patients.
Employees: 11-50
Portfolio 28
| Date | Name | Website | Total Raised | Location |
| 10.03.2026 | Sentynl Th... | sentynl.com | - | - |
| 01.02.2026 | Alveus The... | alveustx.com | - | Denmark |
| 01.02.2026 | EpiBiologi... | epibiologics.com | $157M | United Sta... |
| 11.11.2025 | myTomorrow... | mytomorrows.com | $47.63M | Netherland... |
| 17.10.2025 | Ensho Ther... | enshorx.com | - | - |
| 17.10.2025 | Aro Biothe... | arobiotx.com | $65.5M | United Sta... |
| 17.10.2025 | MapLight T... | maplightrx.com | $225M | United Sta... |
| 17.10.2025 | CellCentri... | cellcentric.com | $171M | United Kin... |
| 04.07.2025 | Evommune | evommune.com | $405.5M | United Sta... |
| 04.07.2025 | Alentis Th... | alentis.ch | $367.06M | Switzerlan... |
Show more
Persons 9
| Date | First Name | Last Name | Title | Location | |||
| - | Long | Yip | Associate | - | - | - | |
| - | Morgan | Berk | Director o... | - | - | - | |
| - | Tom | Marino | Assistant ... | - | - | - | |
| - | Christy | Kuo, PhD | Principal | - | - | - | |
| - | Ivan | Martin | Head of Bu... | - | - | - | |
| - | Steve | Jo | Senior Ass... | - | - | - | |
| - | Alyssa | Romano | Chief Fina... | - | - | - | |
| - | Eric | Pham, PhD | Managing D... | - | - | - | |
| - | Greg | Balani, Ph... | Senior Ass... | - | - | - |
News 15
| Date | Title | Description |
| 01.06.2023 | AtomVie Global Radiopharma raises over $90M to Complete its New Facility Buildout | HAMILTON, ON /CNW/ – AtomVie Global Radiopharma Inc. (AtomVie), a global-leading CDMO for the GMP manufacturing and worldwide distribution of radiopharmaceuticals, today announced the closing of its Tranche 2 Series A financing led by its c... |
| 27.03.2023 | Alimera Improves Capital Structure, Strengthens Balance Sheet and Extends Term Loan Facility | ATLANTA (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision... |
| 09.01.2023 | PBS Biotech Raises $22M to Expand Single-Use Manufacturing Products and Services for Cell Therapy Clients | CAMARILLO, Calif. /PRNewswire/ — PBS Biotech (“PBS”), an innovative, single-use bioreactor manufacturer and process development services provider, has completed a $22 million financing led by Avego Management, LLC (“Avego”) with additional ... |
| 28.11.2022 | Escient Pharmaceuticals Announces $120 Million Series C Financing | SAN DIEGO–(BUSINESS WIRE)–Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, today announced the closing of a $1... |
| 24.08.2022 | AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego | HAMILTON ON /PRNewswire/ – AtomVie Global Radiopharma Inc. (“AtomVie”) today announced the successful closing of its Series A financing with Avego Management, LLC (“Avego”), a healthcare investment firm. AtomVie is a global leading CDMO (Co... |
| 05.01.2022 | Amneal Acquires Saol Therapeutics’ Baclofen Franchise | BRIDGEWATER, N.J. & ROSWELL, Ga.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) and Saol Therapeutics, a private specialty pharmaceutical company (“Saol”), today announced a definitive agreement under which Amneal ... |
| 07.12.2021 | Saol Therapeutics Announces FDA Approval of LYVISPAH™ (baclofen) Oral Granules and the Divesture of its Plasma-derived Hyperimmune Portfolio | ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda /PRNewswire/ — Saol Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved Saol’s LYVISPAH™ (baclofen) oral granules. |
| 10.11.2021 | Ellie Diagnostics Raises Growth Equity from Avego Healthcare Capital | DALLAS /PRNewswire/ — Ellie Diagnostics is pleased to announce a new capital partnership with Avego Healthcare Capital. Through this strategic investment, Avego will support Ellie in the expansion of its unique position as the leading indep... |
| 03.11.2021 | Antios Therapeutics Raises $75 Million in a Series B-1 Funding to Advance Clinical Programs for HBV | MENDHAM, N.J. /PRNewswire/ — Antios Therapeutics, Inc. (“Antios”), a clinical-stage biopharmaceutical company developing innovative therapies to treat and cure chronic hepatitis B virus (HBV), today announced the successful closing of a $75... |
| 24.09.2021 | Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation | REDWOOD CITY, Calif.–(BUSINESS WIRE)–Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today announced the completion of its business combination with Amplitude Healthcare Acquisition Cor... |
Show more
Mentions in press and media 11
| Date | Title | Description |
| 12.11.2025 | HealthTech Pioneer myTomorrows Lands $29M to Boost Global Patient Access | myTomorrows, a Dutch HealthTech innovator, just secured a $29 million investment from Avego. This capital injection propels its global mission. The company bridges the critical gap between emerging therapies and patients in need. Its AI-dri... |
| 11.11.2025 | As millions await approved therapies, myTomorrows strengthens its global patient-access mission with €25 million | myTomorrows, a Dutch HealthTech company that connects patients with possible pre-approval treatments, today announced the close of a €25 million financing in order to accelerate the global expansion of its AI-driven platform and enhance acc... |
| 11.11.2025 | myTomorrows Secures $29M to Fuel Global Expansion of Pre-Approval Therapy Access | What You Should Know: – myTomorrows, a health technology company that connects patients with all possible pre-approval treatments, today announced the close of a $29 million financing with Avego. Avego’s growth equity investment will fuel t... |
| 13.11.2024 | Alentis Therapeutics Secures $181.4 Million to Pioneer Cancer Treatments | In a bold move to reshape cancer treatment, Alentis Therapeutics has successfully raised $181.4 million in an oversubscribed Series D funding round. This infusion of capital, led by OrbiMed and co-led by Novo Holdings and Jeito Capital, sig... |
| 12.11.2024 | Alentis Therapeutics raises $181.4 million in oversubscribed series D round | Normal 0 false false false EN-GB X-NONE AR-SA Besides OrbiMed, Novo Holdings and Jeito Capital, Alentis Therapeutics’ series D round saw the participation of new investors Frazier Life Sciences, Longitude Capital, Catalio Capital, Piper Hea... |
| 01.06.2023 | AtomVie Global Radiopharma raises over $90M to Complete its New Facility Buildout | HAMILTON, ON, June 1, 2023 /PRNewswire/ -- AtomVie Global Radiopharma Inc. (AtomVie), a global-leading CDMO for the GMP manufacturing and worldwide distribution of radiopharmaceuticals, today announced the closing of its Tranche 2 Series A ... |
| 24.08.2022 | AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego | HAMILTON ON, Aug. 24, 2022 /PRNewswire/ -- AtomVie Global Radiopharma Inc. ("AtomVie") today announced the successful closing of its Series A financing with Avego Management, LLC ("Avego"), a healthcare investment firm. ... |
| 22.04.2013 | 4 apps to keep you green in more ways than one | (MoneyWatch) Earth Day is a good reminder that we all can do things to improve the environment -- to be "green." And while being good to the place you call home is always a good idea, how much better is it to get two benefits for ... |
| 26.07.2012 | Carpooling targets the U.S. market with investment from Daimler | Being a backseat driver may no longer be a bad thing. Luxury car brand Daimler AG just invested an undisclosed amount in ride-sharing startup Carpooling. Although Munich, Germany-based Carpooling declined to specify the size of the investme... |
| 26.07.2012 | Carpooling targets the U.S. market with investment from Daimler | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! Being a backseat driver may no longer be a bad th... |
Show more